Carmen Peral - Pfizer, SLU | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 16 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Economic and Humanistic Burden of Moderate and Severe Hemophilia A and B in Spain: Real-World Evidence Insights from the CHESS II Study

Carmen Peral,Alfonso de Lossada Juste, Nadia Lwoff, Nataly Espinoza-Camac,Miguel Angel Casado,Tom Burke,Jose Alvir,Sheena Thakkar,Enrico Ferri Grazzi

JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCHno. 1 (2024): 122-133

引用0浏览0WOS引用

Real-World Healthcare Outcomes and Costs among Patients with Juvenile Idiopathic Arthritis in Spain

Jordi Anton,Estefania Moreno Ruzafa,Mireia Lopez Corbeto,Rosa Bou,Judith Sanchez Manubens,Sonia Carriqui Arenas,Joan Calzada Hernandez,Violetta Bittermann, Carolina Estepa Guillen, Juan Mosquera Angarita, Lucia Rodriguez Diez,Estibaliz Iglesias,Miguel Marti Masanet,Berta Lopez Montesinos,Maria Isabel Gonzalez Fernandez, Alfonso de Lossada,Carmen Peral,Monica Valderrama,Noelia Llevat,Maria Montoro Alvarez,Immaculada Calvo Penades

JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCHno. 2 (2023): 141-149

引用0浏览0WOS引用

Adherence differences in Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) dimensions

Carmen Peral, Lidia Castro Feijoo,Jose I. Labarta, Antonio de Arriba,Isabel Gonzalez Casado, Maria Jose Martinez-Aedo,Diego Yeste, Gerardo Villa,Jon Andoni Barrueta,Miguel Ruiz

QUALITY OF LIFE RESEARCH (2022): S103-S104

引用0浏览0引用

Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with Cssti: an Economic Analysis from the Perspective of the Spanish National Health System

Antoni Torres,Alex Soriano,Simone Rivolo,Edit Remak,Carmen Peral,Michal Kantecki,Wajeeha Ansari,Claudie Charbonneau,Jennifer Hammond,Santiago Grau,Mark Wilcox

ClinicoEconomics and Outcomes Research（2022）

引用4浏览0WOS引用

Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain

Carlos Taxonera,Fernando de Andres-Nogales,Santiago Garcia-Lopez,Amelia Sanchez-Guerrero, Belen Menchen,Carmen Peral,Ana Cabez,Susana Gomez,Alejandra Lopez-Ibanez de Aldecoa,Miguel Angel Casado,Luis Menchen

Expert review of pharmacoeconomics & outcomes research（2022）

引用3浏览0WOS引用

Cost of patients with hemophilia A treated with standard half-life or extended half-life FVIII in Spain

Hae Kyung Kim,Carmen Peral,Dario Rubio-Rodriguez,Carlos Rubio-Terres

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH（2021）

引用4浏览0WOS引用

Estimating the Annual Economic Burden for the Management of Patients with Transthyretin Amyloid Polyneuropathy in Spain

Lucia Galan,Juan Gonzalez-Moreno,Jose Manuel Martinez-Sesmero,Francisco Munoz-Beamud,Maria Dolores Santos-Rubio,Diana Tran, Paul Lebeau,Michelle Stewart,Pablo Mallaina,Patricia Tarilonte,Carmen Peral,Mark H. Rozenbaum

Expert review of pharmacoeconomics & outcomes research（2021）

引用2浏览0WOS引用

PCV24 Health and Economic IMPACT of the Correct Diagnosis of Transthyretin Cardiac Amyloidosis in Spain

Carmen Peral,Françesc Formiga, P. García, J Martin-Sanchez, A Navarro-Ruiz,P. Tarilonte, A. López,Darío Rubio-Rodríguez,Carlos Rubio-Terrés

Value in health（2020）

引用0浏览0引用

The Cost‐effectiveness of Isavuconazole Compared to Voriconazole, the Standard of Care in the Treatment of Patients with Invasive Mould Diseases, Prior to Differential Pathogen Diagnosis in Spain

Jose Ramon Azanza,Santiago Grau,Lourdes Vazquez,Pablo Rebollo,Carmen Peral,Alejandra Lopez-Ibanez de Aldecoa, Vanessa Lopez-Gomez

Mycoses（2020）

引用7浏览0WOS引用

THU0187 EFFICIENCY OF TREATMENT SEQUENCES CONTAINING TOFACITINIB FOR RHEUMATOID ARTHRITIS IN SPAIN

Carmen Peral,Alejandro Balsa,Federico Navarro,José Luis Pablos,Jose Manuel Martinez Sesmero,Susana Gómez,Monica Valderrama,Itziar Oyagüez,Miguel Angel Casado, Fernando De Andres,Maria Montoro

ANNALS OF THE RHEUMATIC DISEASES（2019）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn